Literature DB >> 33661479

Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.

Umar Mehraj1, Hina Qayoom1, Manzoor A Mir2.   

Abstract

Macrophages are phagocytic sentinel cells of the immune system that are central to both innate and adaptive immune responses and serve as the first line of defense against pathogenic insults to tissues. In the tumor microenvironment, tumor-derived factors induce monocyte polarization towards a pro-tumor phenotype. The pro-tumor macrophages regulate key steps in tumorigenicity including tumor growth, angiogenesis, immune suppression, and metastasis. Macrophage infiltration in solid tumors correlates with poor prognosis and resistance to chemotherapy in most cancers. Here in this review, we will shed light on tumor-associated macrophages (TAMs) in regulating tumorigenicity and TAMs as a prognostic biomarker. Also, we will review the recent advances in targeting TAMs to increase the prognosis of cancer patients.

Entities:  

Keywords:  Cancer; Immunosuppression; Monocyte recruitment; Prognosis; Reprogramming TAMs; TAMs; Tumor microenvironment

Year:  2021        PMID: 33661479     DOI: 10.1007/s12282-021-01231-2

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  156 in total

Review 1.  Monocyte and macrophage heterogeneity.

Authors:  Siamon Gordon; Philip R Taylor
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

Review 2.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions.

Authors:  Subhra K Biswas; Paola Allavena; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-05-09       Impact factor: 9.623

3.  The good and bad of microglia/macrophages: new hope in stroke therapeutics.

Authors:  Ya-chi Huang; Zhong-ping Feng
Journal:  Acta Pharmacol Sin       Date:  2012-12-24       Impact factor: 6.150

4.  CD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation.

Authors:  Wang Zhang; Chunyan Zhang; Wenzhao Li; Jiehui Deng; Andreas Herrmann; Saul J Priceman; Wei Liang; Shudan Shen; Sumanta K Pal; Dave S B Hoon; Hua Yu
Journal:  Eur J Immunol       Date:  2014-11-10       Impact factor: 5.532

Review 5.  Myeloid cells in cancer-related inflammation.

Authors:  Nicoletta Caronni; Benedetta Savino; Raffaella Bonecchi
Journal:  Immunobiology       Date:  2014-10-14       Impact factor: 3.144

Review 6.  Human mononuclear phagocyte system reunited.

Authors:  Muzlifah Haniffa; Venetia Bigley; Matthew Collin
Journal:  Semin Cell Dev Biol       Date:  2015-05-15       Impact factor: 7.727

7.  Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation.

Authors:  Ruth A Franklin; Ming O Li
Journal:  Trends Cancer       Date:  2016-10-01

Review 8.  From the Reticuloendothelial to Mononuclear Phagocyte System - The Unaccounted Years.

Authors:  Simon Yona; Siamon Gordon
Journal:  Front Immunol       Date:  2015-07-01       Impact factor: 7.561

Review 9.  Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression.

Authors:  Damya Laoui; Eva Van Overmeire; Patrick De Baetselier; Jo A Van Ginderachter; Geert Raes
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

Review 10.  CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.

Authors:  Matteo Santoni; Sergio Bracarda; Massimo Nabissi; Francesco Massari; Alessandro Conti; Emilio Bria; Giampaolo Tortora; Giorgio Santoni; Stefano Cascinu
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

View more
  8 in total

Review 1.  Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.

Authors:  Shazia Sofi; Umar Mehraj; Hina Qayoom; Shariqa Aisha; Syed Mohammad Basheeruddin Asdaq; Abdullah Almilaibary; Manzoor A Mir
Journal:  Med Oncol       Date:  2022-04-29       Impact factor: 3.064

2.  Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study.

Authors:  Hina Qayoom; Umar Mehraj; Shazia Sofi; Shariqa Aisha; Abdullah Almilaibary; Mustfa Alkhanani; Manzoor Ahmad Mir
Journal:  Med Oncol       Date:  2022-07-23       Impact factor: 3.738

3.  Expression patterns and therapeutic implications of histone deacetylase-1 across carcinomas: a comprehensive molecular docking and MD simulation study.

Authors:  Bader Alshehri
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

Review 4.  Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.

Authors:  Mohammad Fereydouni; Mona Motaghed; Elnaz Ahani; Tal Kafri; Kristen Dellinger; Dean D Metcalfe; Christopher L Kepley
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

5.  Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941.

Authors:  Umar Mehraj; Nissar Ahmad Wani; Abid Hamid; Mustfa Alkhanani; Abdullah Almilaibary; Manzoor Ahmad Mir
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

6.  Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors.

Authors:  Shazia Sofi; Umar Mehraj; Hina Qayoom; Shariqa Aisha; Abdullah Almilaibary; Mustfa Alkhanani; Manzoor Ahmad Mir
Journal:  Med Oncol       Date:  2022-06-20       Impact factor: 3.738

7.  The Prognostic and Clinical Value of Tumor-Associated Macrophages in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Changjun Wang; Yan Lin; Hanjiang Zhu; Yidong Zhou; Feng Mao; Xin Huang; Qiang Sun; Chenggang Li
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

8.  Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma.

Authors:  Omar Samir; Naohiro Kobayashi; Teppei Nishino; Mennatullah Siyam; Manoj Kumar Yadav; Yuri Inoue; Satoru Takahashi; Michito Hamada
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.